ArticleBMC bioinformatics2011
Development of a classification scheme for disease-related enzyme information.
Article in BMC bioinformatics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Helping authors produce FAIR taxonomic data: evaluation of an author-driven phenotype data production prototype.Database : the journal of biological databases and curation · 2025Article
- BRENDA, the ELIXIR core data resource in 2021: new developments and updates.Nucleic acids research · 2021Article
- Measurement Recorder: developing a useful tool for making species descriptions that produces computable phenotypes.Database : the journal of biological databases and curation · 2020Article
- BRENDA in 2019: a European ELIXIR core data resource.Nucleic acids research · 2019Article
- Annotation of phenotypes using ontologies: a gold standard for the training and evaluation of natural language processing systems.Database : the journal of biological databases and curation · 2018Article
- BRENDA in 2017: new perspectives and new tools in BRENDA.Nucleic acids research · 2017Article
- Article
- BRENDA in 2015: exciting developments in its 25th year of existence.Nucleic acids research · 2015Article
- The plant ontology as a tool for comparative plant anatomy and genomic analyses.Plant & cell physiology · 2013Article
- BRENDA in 2013: integrated reactions, kinetic data, enzyme function data, improved disease classification: new options and contents in BRENDA.Nucleic acids research · 2013Article
- Bioinformatic approaches for functional annotation and pathway inference in metagenomics data.Briefings in bioinformatics · 2012Review
- The relationship between proteome size, structural disorder and organism complexity.Genome biology · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBRENDA (BRaunschweig ENzyme DAtabase, http://www.brenda-enzymes.org) is a major resource for enzyme related information. First and foremost, it provides data which are manually curated from the primary literature. DRENDA (Disease RElated ENzyme information DAtabase) complements BRENDA with a focus on the automatic search and categorization of enzyme and disease related information from title and abstracts of primary publications. In a two-step procedure DRENDA makes use of text mining and machine learning methods.
resultsCurrently enzyme and disease related references are biannually updated as part of the standard BRENDA update. 910,897 relations of EC-numbers and diseases were extracted from titles or abstracts and are included in the second release in 2010. The enzyme and disease entity recognition has been successfully enhanced by a further relation classification via machine learning. The classification step has been evaluated by a 5-fold cross validation and achieves an F1 score between 0.802 ± 0.032 and 0.738 ± 0.033 depending on the categories and pre-processing procedures. In the eventual DRENDA content every category reaches a classification specificity of at least 96.7% and a precision that ranges from 86-98% in the highest confidence level, and 64-83% for the smallest confidence level associated with higher recall.
conclusionsThe DRENDA processing chain analyses PubMed, locates references with disease-related information on enzymes and categorises their focus according to the categories causal interaction, therapeutic application, diagnostic usage and ongoing research. The categorisation gives an impression on the focus of the located references. Thus, the relation categorisation can facilitate orientation within the rapidly growing number of references with impact on diseases and enzymes. The DRENDA information is available as additional information in BRENDA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.